271 related articles for article (PubMed ID: 31724338)
1. Alpha-calcitonin gene-related peptide prevents pressure-overload induced heart failure: role of apoptosis and oxidative stress.
Kumar A; Supowit S; Potts JD; DiPette DJ
Physiol Rep; 2019 Nov; 7(21):e14269. PubMed ID: 31724338
[TBL] [Abstract][Full Text] [Related]
2. Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure.
Li J; Levick SP; DiPette DJ; Janicki JS; Supowit SC
Regul Pept; 2013 Aug; 185():20-8. PubMed ID: 23816470
[TBL] [Abstract][Full Text] [Related]
3. A Novel Alginate-Based Delivery System for the Prevention and Treatment of Pressure-Overload Induced Heart Failure.
Kumar A; Belhaj M; DiPette DJ; Potts JD
Front Pharmacol; 2020; 11():602952. PubMed ID: 33603665
[No Abstract] [Full Text] [Related]
4. Distinct changes of myocyte autophagy during myocardial hypertrophy and heart failure: association with oxidative stress.
Li B; Chi RF; Qin FZ; Guo XF
Exp Physiol; 2016 Aug; 101(8):1050-63. PubMed ID: 27219474
[TBL] [Abstract][Full Text] [Related]
5. Genetic ablation of TRPV1 exacerbates pressure overload-induced cardiac hypertrophy.
Zhong B; Rubinstein J; Ma S; Wang DH
Biomed Pharmacother; 2018 Mar; 99():261-270. PubMed ID: 29334670
[TBL] [Abstract][Full Text] [Related]
6. Alamandine improves cardiac remodeling induced by transverse aortic constriction in mice.
Silva MM; de Souza-Neto FP; Jesus ICG; Gonçalves GK; Santuchi MC; Sanches BL; de Alcântara-Leonídio TC; Melo MB; Vieira MAR; Guatimosim S; Santos RAS; da Silva RF
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H352-H363. PubMed ID: 33124885
[TBL] [Abstract][Full Text] [Related]
7. Dapagliflozin Attenuates Cardiac Remodeling in Mice Model of Cardiac Pressure Overload.
Shi L; Zhu D; Wang S; Jiang A; Li F
Am J Hypertens; 2019 Apr; 32(5):452-459. PubMed ID: 30689697
[TBL] [Abstract][Full Text] [Related]
8. A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure.
Aubdool AA; Thakore P; Argunhan F; Smillie SJ; Schnelle M; Srivastava S; Alawi KM; Wilde E; Mitchell J; Farrell-Dillon K; Richards DA; Maltese G; Siow RC; Nandi M; Clark JE; Shah AM; Sams A; Brain SD
Circulation; 2017 Jul; 136(4):367-383. PubMed ID: 28446517
[TBL] [Abstract][Full Text] [Related]
9. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
11. Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload.
O'Shea KM; Chess DJ; Khairallah RJ; Rastogi S; Hecker PA; Sabbah HN; Walsh K; Stanley WC
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H1639-45. PubMed ID: 20348222
[TBL] [Abstract][Full Text] [Related]
12. CRD-733, a Novel PDE9 (Phosphodiesterase 9) Inhibitor, Reverses Pressure Overload-Induced Heart Failure.
Richards DA; Aronovitz MJ; Liu P; Martin GL; Tam K; Pande S; Karas RH; Bloomfield DM; Mendelsohn ME; Blanton RM
Circ Heart Fail; 2021 Jan; 14(1):e007300. PubMed ID: 33464954
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.
Zhao L; Cheng G; Jin R; Afzal MR; Samanta A; Xuan YT; Girgis M; Elias HK; Zhu Y; Davani A; Yang Y; Chen X; Ye S; Wang OL; Chen L; Hauptman J; Vincent RJ; Dawn B
Circ Res; 2016 Jun; 118(12):1918-1929. PubMed ID: 27126808
[TBL] [Abstract][Full Text] [Related]
14. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress regulates left ventricular PDE5 expression in the failing heart.
Lu Z; Xu X; Hu X; Lee S; Traverse JH; Zhu G; Fassett J; Tao Y; Zhang P; dos Remedios C; Pritzker M; Hall JL; Garry DJ; Chen Y
Circulation; 2010 Apr; 121(13):1474-83. PubMed ID: 20308615
[TBL] [Abstract][Full Text] [Related]
16. The disruption of invariant natural killer T cells exacerbates cardiac hypertrophy and failure caused by pressure overload in mice.
Takahashi M; Kinugawa S; Takada S; Kakutani N; Furihata T; Sobirin MA; Fukushima A; Obata Y; Saito A; Ishimori N; Iwabuchi K; Tsutsui H
Exp Physiol; 2020 Mar; 105(3):489-501. PubMed ID: 31957919
[TBL] [Abstract][Full Text] [Related]
17. Alpha-Calcitonin Gene Related Peptide: New Therapeutic Strategies for the Treatment and Prevention of Cardiovascular Disease and Migraine.
Kumar A; Williamson M; Hess A; DiPette DJ; Potts JD
Front Physiol; 2022; 13():826122. PubMed ID: 35222088
[TBL] [Abstract][Full Text] [Related]
18. Experimental model of congestive heart failure induced by transverse aortic constriction in BALB/c mice.
Tannu S; Allocco J; Yarde M; Wong P; Ma X
J Pharmacol Toxicol Methods; 2020; 106():106935. PubMed ID: 33096237
[TBL] [Abstract][Full Text] [Related]
19. Variable phenotype in murine transverse aortic constriction.
Mohammed SF; Storlie JR; Oehler EA; Bowen LA; Korinek J; Lam CS; Simari RD; Burnett JC; Redfield MM
Cardiovasc Pathol; 2012; 21(3):188-98. PubMed ID: 21764606
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of recombinant human erythropoietin against pressure overload-induced left ventricular remodeling and premature death in mice.
Wang W; Kagaya Y; Asaumi Y; Fukui S; Takeda M; Shimokawa H
Tohoku J Exp Med; 2011 Oct; 225(2):131-43. PubMed ID: 21937860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
